Insiders Tectonic Therapeutic, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
16.47 ^USD	-0.12%		-3.17%	+0.92%

06-20	Avrobio Closes Merger With Tectonic Therapeutic	MT
06-20	Tectonic Therapeutic, Inc. announced that it has received $96.599856 million in funding from Tas Partners, LLC	CI

Avrobio Insider Bought Shares Worth $971,493, According to a Recent SEC Filing	05-15	MT
AVROBIO, Inc. Announces Resignation of Geoff Mackay as President	02/05/23	CI
AVROBIO, Inc. Announces CEO Changes	02/05/23	CI
AVROBIO Appoints Erik Ostrowski as Interim Chief Executive	01/05/23	MT
AVROBIO, Inc. Announces the Appointment of Sean O’Bryan as Chief Regulatory Officer	01/02/22	CI
AVROBIO, Inc. Announces Appointment of Essra Ridha as Chief Medical Officer	26/10/21	CI
AVROBIO, Inc. Appoints Diana M. Escolar as Chief Medical Officer	19/01/21	CI
Avrobio, Inc. Appoints Dr. Gail Farfel to Its Board of Directors	21/10/20	CI
AVROBIO, Inc. Announces Executive Changes	29/06/20	CI
AVROBIO Appoints Holly May as Chief Commercial Officer	22/10/19	CI
Avrobio Appoints Georgette Verdin as Chief Human Resources Officer	26/08/19	CI
AVROBIO, Inc. Appoints Georgette Verdin as Chief Human Resources Officer	16/08/19	CI
AVROBIO, Inc. Announces Board Changes	07/01/19	CI
AVROBIO, Inc. Announces Management Changes	18/12/18	CI
AVROBIO, Inc. Announces the Resignation of Joshua Resnick as Member of the Board of Directors	24/09/18	CI
AVROBIO, Inc. Elects Phillip B. Donenberg to Board of Directors	25/06/18	CI
AVROBIO Inc. Appoints Annalisa Jenkins to Board of Directors	04/04/18	CI
AVROBIO, Inc. Appoints Ian Clark to Board of Directors	09/11/17	CI
Avrobio, Inc. Announces Appointment of Katina Dorton as Chief Financial Officer	26/09/17	CI
AVROBIO Inc. Announces Executive Appointments	09/11/16	CI

No results for this search